PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery.

Authors:
Sheffey VV; Siew EB; Tanner EEL; Eniola-Adefeso O.

Journal:
Adv Healthc Mater

Publication Year: 2022

DOI:
10.1002/adhm.202101536

PMCID:
PMC9035064

PMID:
35032406

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Adv Healthc Mater

Abbreviation: Adv Healthc Mater

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biomedical Engineering

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Enzyme-Triggered Intestine-Specific Targeting Adhesive Platform for Universal Oral Drug Delivery.
Li Y; Lee JS; Kirtane AR and 11 more (2023) - Transparency Score: 3/6
New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay.
Wan Z; Floryan MA; Coughlin MF and 7 more (2022) - Transparency Score: 3/6
Tissue Engineering Cartilage with Deep Zone Cytoarchitecture by High-Resolution Acoustic Cell Patte…
Armstrong JPK; Pchelintseva E; Treumuth S and 7 more (2022) - Transparency Score: 3/6
Tunable Microgel-Templated Porogel (MTP) Bioink for 3D Bioprinting Applications.
Ouyang L; Wojciechowski JP; Tang J and 3 more (2022) - Transparency Score: 4/6
3D Printed Porous Methacrylate/Silica Hybrid Scaffold for Bone Substitution.
Chung JJ; Yoo J; Sum BST and 8 more (2021) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest The authors declare no conflict of interest."

Evidence found in paper:

"Portions of Figures 2, 4, and 9 were created using BioRender.com. Figure 1 was entirely constructed on BioRender.com. This work was supported by the National Science Foundation Graduate Research Fellowship Program (V.V.S.) and NIH R01 HL145709 (O.E.‐A.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025